In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.

Community moderators

Masoud Dara, MD - WHO Europe - EURO Christopher Gilpin, PhD, MPH - World Health Organization - WHO Dylan Tierney, MD, MPH - Brigham and Women's Hospital, Division of Global Health Equity
Two MSF TB statements: MSF AC response to USAID/Janssen announcement on BDQ donation programme; BRICS countries must boost investments in research to defeat deadly DRTB crisis

I fullyagree that getting free donations for short period of time is not the long term solution of providing resaonably priced BEDAQUILIN

By Michelle French on 12 Dec 2014 0 Recommendations 3 Replies
Free bedaquiline for 100 countries

I fully agree with Prof. Jose A. Caminero, MD and I had raised almost same concerns in my previous mail in this forum and I have no hesitation to say that WHO should give more importance to linezolid which has a better toxicity profile and have better…

By Masoud Dara, MD on 12 Dec 2014 0 Recommendations 16 Replies
From Silos to Systems: Improving Knowledge Sharing for Public Health

On December 5, 2014, Ministers of Health from Brazil, Russia, India, China and South Africa (BRICS), countries, which collectively account for almost 50% of global TB cases, made a historic commitment to provide first line TB medicines for all people with…

By Stephan Rabimov on 12 Dec 2014 1 Recommendations 0 Replies
FIND is recruiting: Senior Scientific Officer - Tuberculosis

By Claudia Denkinger on 28 Nov 2014 0 Recommendations 0 Replies
Staining methods for detection of AFB in urine sample

Agree. Molecular confirmation will be more helpful than Urine smear microscopy.

By Karchung Tshering on 27 Nov 2014 0 Recommendations 4 Replies
Excellent article on TB

The two studies that Erica cited are probably the best randomized prospective data that we have on linezolid efficacy in DR-TB. There are still, however, many unanswered questions about the drug's best dose and duration of therapy given its significant…

By Erica Lessem on 26 Nov 2014 0 Recommendations 6 Replies

Dr. Kathleen England, Greetings from Bangladesh! I shall appreciate if you could send me your communicating email to have some information about the TB situation in Myanmar and other laboratory issues. Regards and best wishes. Dr. Md. Zeaur Rahim…

By Indrajit Kumar on 23 Nov 2014 1 Recommendations 21 Replies
Do we care enough about cigarette smoking?

Dear Dylan, Thank you so much for proposing this topic! It is a great point! I come from China, so I might want to talk about your question based on China's current situation. Actually, smoking has already been recognized as a risk factor for many disease,…

By Dylan Tierney, MD, MPH on 17 Nov 2014 1 Recommendations 1 Replies
A nice talk on operation Asha/ TEDx

Dear colleagues, A very nice talk by Dr Shelly Batra at TEDxWBG and how Operation Asha works in India with a focus on addressing stigma, improving adherence, using technology cost consciously and replicable.…

By Masoud Dara, MD on 16 Nov 2014 0 Recommendations 0 Replies
New Cochrane Systematic Review and Meta-analysis on the Hain MTBDRsl line probe assay

Thanks Grant T for sharing such an informative article.

By Grant T on 08 Nov 2014 1 Recommendations 1 Replies
New Medicines and Novel Approaches for MDR-TB

Thank you so much Amoud for your very kind and helpful response which actually cleared number of questions but opened up for more queries. However, I would wait to see more details when the study is published later on. With this I cc. Dr. Caminero for…

By Masoud Dara, MD on 18 Mar 2014 6 Recommendations 92 Replies
The Updated WHO Policy on Xpert MTB/RIF assay: What is New and How it May Support Implementation

Dear all I wander the one who answer the question of the training of GeneXpert. Belayneh

By Fuad Mirzayev on 16 Jan 2014 2 Recommendations 202 Replies
Creating Opportunities for Health Scientists in Disease Endemic Countries

Hi Chris, I was not aware of AfricaOER - looks like a great resource. Some time ago (perhaps 4-6 months), there was a discussion on the Global Public Health group on Linked In about open resources in public health - and a lot were listed. However, it seems…

By Sungano Mharakurwa on 09 Aug 2013 0 Recommendations 75 Replies
Lessons Learned in India: E-Compliance for TB Treatment by Operation ASHA

Hi Ruth, many thanks for this idea and if you'd like to work with us to plan a virtual Expert Panel on this topic happy to work with you on this! Please email me at or To all, we're…

By Sophie Beauvais on 05 Jul 2013 5 Recommendations 75 Replies
More posts